← Leaderboards
William Bernard Weglicki
George Washington University
$9,137,690
Attributed
$9,137,690
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$9,137,690 · 5
By mechanism
R01$8,318,173 · 3
R21$428,267 · 1
R56$391,250 · 1
Top collaborators
No co-investigators on record.
Most similar at George Washington University
Same institution · by research overlap
- Imtiaz Ahmed Khan$17,438,381
Others in their field
Top investigators on “Oxidative Stress”
- Leonardo Trasande · New York University School Of Medicine$57,471,048
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$36,739,005
- Claire Gmachl · Princeton University$34,397,540
- Akram N Alshawabkeh · Northeastern University$31,872,089
- Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach)$31,629,832
- Robert O Wright · Brigham And Women'S Hospital$30,479,869
Research focus
Oxidative StressLaboratory RatMagnesium DeficiencyAntioxidantsInflammationNmda ReceptorsReperfusionMyocardial Ischemia /HypoxiaLysosomesSubstance PCardiacInjuryFunctional DisorderCytokineRattusIn VivoPharmaceutical PreparationsPredispositionGenerationsApoptosisChronicAttenuatedHeartIron
Grant awards (29)
EGFR Tyrosine Kinase Inhibition - Induced Cardiomyopathy$150,892
R21 · FY2013 · HL · contact PI
EGFR Tyrosine Kinase Inhibition - Induced Cardiomyopathy$277,375
R21 · FY2012 · HL · contact PI
Oxidative Stress And Antioxidants in Iron Overload$385,750
R01 · FY2010 · HL · contact PI
Substance P-mediated Cardiovascular Inflammation$391,250
R56 · FY2009 · HL · contact PI
Oxidative Stress And Antioxidants in Iron Overload$385,750
R01 · FY2009 · HL · contact PI
Oxidative Stress And Antioxidants in Iron Overload$385,750
R01 · FY2008 · HL · contact PI
Oxidative Stress And Antioxidants in Iron Overload$399,000
R01 · FY2007 · HL · contact PI
Cardiomyopathy: Pro-Oxidant Role of Zidovudine (AZT)$326,412
R01 · FY2007 · HL · contact PI
Substance P-Mediated Cardiovascular Inflammation$288,247
R01 · FY2007 · HL · contact PI
Cardiomyopathy:Pro-Oxidant Role of Zidovudine (AZT)$336,161
R01 · FY2006 · HL · contact PI
Substance P-Mediated Cardiovascular Inflammation$296,856
R01 · FY2006 · HL · contact PI
Cardiomyopathy:Pro-Oxidant Role of Zidovudine (AZT)$344,250
R01 · FY2005 · HL
Substance P-Mediated Cardiovascular Inflammation$304,000
R01 · FY2005 · HL
Cardiomyopathy: Pro-Oxidant Role of Zidovudine (AZT)$344,250
R01 · FY2004 · HL
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD$304,000
R01 · FY2004 · HL
Substance P-Mediated Cardiovascular Inflammation$304,000
R01 · FY2004 · HL
CARDIOMYOPATHY:PRO-OXIDANT ROLE OF AZT &MG-DEFICIENCY$342,000
R01 · FY2003 · HL
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATION$319,907
R01 · FY2003 · HL
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD$304,000
R01 · FY2003 · HL
CARDIOMYOPATHY:PRO-OXIDANT ROLE OF AZT &MG-DEFICIENCY$342,000
R01 · FY2002 · HL
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATION$310,591
R01 · FY2002 · HL
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD$304,000
R01 · FY2002 · HL
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATION$366,609
R01 · FY2001 · HL
CARDIOMYOPATHY:PRO-OXIDANT ROLE OF AZT &MG-DEFICIENCY$342,000
R01 · FY2001 · HL
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD$304,000
R01 · FY2001 · HL
CARDIOMYOPATHY:PRO-OXIDANT ROLE OF AZT &MG-DEFICIENCY$342,375
R01 · FY2000 · HL
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD$304,000
R01 · FY2000 · HL
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATION$293,725
R01 · FY2000 · HL
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATION$38,540
R01 · FY2000 · HL